CLARUS THERAPEUTICS HOLDINGS (CRXT)

US18271L1070 - Common Stock

0.099  -0.06 (-36.94%)

After market: 0.101 +0 (+2.02%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

 TTM
(2022-3-31)		 2021
(2021-12-31)		 2020
(2020-12-31)		 2019
(2019-12-31)
CASH FLOWS FROM OPERATING ACTIVITIES
Net Income
-66.14M-40.62M4.34M-41.65M
Depreciation Amortization
N/A25.00K18.00K4.00K
Change In Working Capital
-5.94M-7.25M7.66M-2.28M
Interest Paid
N/A0.003.13M0.00
Other non cash items
11.21M4.05M-53.61M24.21M
OPERATING CASH FLOW
-60.82M-43.79M-41.58M-19.71M
 
CASH FLOWS FROM INVESTING ACTIVITIES
Capital Expenditure
N/A-25.00K-63.00K-21.00K
Other Investing Activity
N/AN/A-58.65MN/A
INVESTING CASH FLOW
N/A-25.00K-63.00K-21.00K
 
CASH FLOWS FROM FINANCING ACTIVITIES
Debt Issued/Reduced
N/A32.18M50.74M18.39M
Stock Issued/Repurchased
N/A13.80M60.95MN/A
Other Financing Activity
N/A17.01M-3.52M-29.00K
FINANCING CASH FLOW
63.01M62.99M47.22M18.36M
 
CHANGE IN CASH
2.15M19.18M5.58M-1.38M
 
FREE CASH FLOW
Operating Cash Flow
-60.82M-43.79M-41.58M-19.71M
Capital Expenditure
N/A-25.00K-63.00K-21.00K
FREE CASH FLOW
N/A-43.81M-41.64M-19.74M

All data in USD

Charts